Transplant Question 26

A patient is being assessed for transplant. He has a panel-reactive antibody (PRA) of 30% by the complement-dependent cytotoxicity (CDC) technique but 0% for Class I and II antigens by flow cytometry (Luminex).

How can you explain the difference between these tests?

Subscribe to Pearls

Uncle Sam wants you to subscribe to Medical Pearls

Subscribe today! It’s always free, and you can easily unsubscribe at any time. We will never share your email address. Subscribe to...

Multiple Pearls
Cardiology Pearls
Endocrinology Pearls
Hematology Pearls
Nephrology Pearls
Rheumatology Pearls
Transplant Pearls
General Internal Medicine Pearls
Instructor Pearls

Subscribe to receive your pearls today—it's free!